PlainBillCongress, translated.Legislation. Context. Public interest.Referred to the House Committee on Energy and Commerce.
Congressional Research Service
No official summary is available in the imported record yet.
People & committees
Rep. Matsui, Doris O. [D-CA-7] · D–CA
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We also preserved the text version used in the PlainBill explanation below.
Source last updated: Dec 5, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.1715 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.1715 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.1715 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.1715 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.
PlainBill explanation
Based on the full Introduced in House · 2025-02-27 text. This explanation has not received human editorial review. This overview describes the proposal’s major provisions; it does not establish what its real-world effects would be.
The proposed Public Health Funding Restoration Act would set funding for the Prevention and Public Health Fund at $2 billion for fiscal year 2026 and every fiscal year afterward. The bill describes the fund as supporting disease and injury prevention through federal, State, local, Tribal, and territorial health agencies. Its stated goal is to sustain and expand prevention programs; the supplied evidence does not establish what results the proposed funding would achieve.
This Act may be cited as the Public Health Funding Restoration Act.
(5) for fiscal year 2026 and each fiscal year thereafter, $2,000,000,000.
(2) Funding under such section is essential to core efforts at the Department of Health and Human Services and in State, local, Tribal, and territorial health departments to prevent and control the spread of infectious disease and prevent injuries and the development of chronic conditions.
(8) Restoring Prevention and Public Health Fund funding to $2,000,000,000 annually will allow the Fund to invest in more innovative, evidence-based public health programs and maintain and expand investments in programs with demonstrated success.
Section 2 presents Congress's proposed findings supporting prevention funding. It describes support for tobacco prevention, nutrition, mental health, childhood lead poisoning prevention, elder care, and immunizations, and says funding helps communities respond to public health threats. These are statements of the bill's rationale, not new program requirements or independently established outcomes.
2. Findings Congress finds the following:
(3) Prevention and Public Health Fund dollars support evidenced-based investments in tobacco use prevention and cessation, nutrition, mental health, childhood lead poisoning prevention, elder care initiatives, and immunizations, among other prevention initiatives. Funding gives States and communities the flexibility to respond to public health threats that may be unique to their communities and bolsters the State, local, Tribal, and territorial response to global public health threats.
Section 3 would replace paragraphs (5) through (10) of the Affordable Care Act's existing fund provision with a single funding amount of $2 billion annually, beginning in fiscal year 2026. The replacement specifies no final fiscal year. It also makes a connecting-word change to paragraph (4).
Section 4002(b) of the Patient Protection and Affordable Care Act (42 U.S.C. 300u–11(b)) is amended— (1) in paragraph (4), by adding at the end and; and (2) by striking paragraphs (5) through (10) and inserting the following: (5) for fiscal year 2026 and each fiscal year thereafter, $2,000,000,000.
The supplied official-actions snapshot, updated December 5, 2025, records introduction in the House and referral to the House Committee on Energy and Commerce on February 27, 2025.
Source snapshot updated 2025-12-05T21:53:21Z. 2025-02-27: Referred to the House Committee on Energy and Commerce. 2025-02-27: Introduced in House
A closer look
Reviewed version: Introduced in House · 2025-02-27. These findings describe provisions and who may benefit; they are not judgments of waste, corruption, or motive.
This review covers the supplied bill text. “None identified” does not rule out provisions in later versions or accompanying reports and disclosures.
Provisions outside the bill’s main subject, or policy changes attached to appropriations.
None identified in the reviewed text
No unrelated provision or separate policy rider was identified in the complete supplied introduced text. This conclusion is limited to that version and does not establish absence in other versions or accompanying materials.
Spending directed to particular recipients or places outside ordinary competitive or formula-based allocation.
None identified in the reviewed text
No congressionally directed spending for a particular recipient or place was identified in the complete supplied introduced text. This conclusion is limited to that version; general fund-level funding does not by itself establish an earmark.
Narrow exceptions, exemptions, or preferential treatment that warrant a closer look.
None identified in the reviewed text
No materially narrow carve-out, special exemption, or preferential treatment was identified in the complete supplied introduced text. This conclusion is limited to that version; ordinary program beneficiaries alone do not constitute a targeted benefit.
Full text preserved for this analysis. Legislative record snapshot: Dec 5, 2025. How PlainBill uses AI